Wockhardt Limited (WOCKPHARMA.NS)
INR 1266.0
(4.37%)
INR 1266.0
(4.37%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 76.49 Billion INR | -0.44% |
| 2022 | 76.83 Billion INR | -6.79% |
| 2021 | 82.43 Billion INR | 6.05% |
| 2020 | 77.72 Billion INR | -4.97% |
| 2019 | 81.78 Billion INR | 4.44% |
| 2018 | 78.31 Billion INR | -4.05% |
| 2017 | 81.62 Billion INR | -8.99% |
| 2016 | 89.68 Billion INR | 12.78% |
| 2015 | 79.52 Billion INR | 14.6% |
| 2014 | 69.38 Billion INR | 4.78% |
| 2013 | 66.22 Billion INR | 9.64% |
| 2012 | 60.4 Billion INR | -3.42% |
| 2011 | 62.53 Billion INR | 6.2% |
| 2010 | 58.88 Billion INR | 2.84% |
| 2009 | 57.25 Billion INR | -14.9% |
| 2008 | 67.28 Billion INR | 30.56% |
| 2007 | 51.53 Billion INR | 38.74% |
| 2006 | 37.14 Billion INR | 72.84% |
| 2005 | 21.48 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 76.49 Billion INR | 0.0% |
| 2023 FY | 76.49 Billion INR | -0.44% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 74.2 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 78.34 Billion INR | 0.0% |
| 2022 FY | 76.83 Billion INR | -6.79% |
| 2022 Q4 | 76.83 Billion INR | 0.0% |
| 2021 FY | 82.43 Billion INR | 6.05% |
| 2021 Q2 | 80.09 Billion INR | 0.0% |
| 2021 Q4 | 82.43 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 77.72 Billion INR | -4.97% |
| 2020 Q2 | 84.69 Billion INR | 0.0% |
| 2020 Q4 | 77.72 Billion INR | 0.0% |
| 2019 FY | 81.78 Billion INR | 4.44% |
| 2019 Q4 | 81.78 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 77.84 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 78.31 Billion INR | 0.0% |
| 2018 FY | 78.31 Billion INR | -4.05% |
| 2018 Q2 | 82.4 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 81.62 Billion INR | -8.99% |
| 2017 Q4 | 81.62 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 83.75 Billion INR | 0.0% |
| 2016 FY | 89.68 Billion INR | 12.78% |
| 2016 Q4 | 89.68 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 90.79 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 FY | 79.52 Billion INR | 14.6% |
| 2015 Q2 | 74.97 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q4 | 79.52 Billion INR | 0.0% |
| 2014 Q2 | 63.94 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 69.38 Billion INR | 4.78% |
| 2014 Q4 | 69.38 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2013 Q2 | 67.98 Billion INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 66.22 Billion INR | 9.64% |
| 2013 Q4 | 66.22 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2012 FY | 60.4 Billion INR | -3.42% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q4 | 60.4 Billion INR | 0.0% |
| 2012 Q2 | 67.25 Billion INR | 0.0% |
| 2011 FY | 62.53 Billion INR | 6.2% |
| 2011 Q4 | 62.53 Billion INR | 0.0% |
| 2010 FY | 58.88 Billion INR | 2.84% |
| 2009 FY | 57.25 Billion INR | -14.9% |
| 2008 FY | 67.28 Billion INR | 30.56% |
| 2007 FY | 51.53 Billion INR | 38.74% |
| 2006 FY | 37.14 Billion INR | 72.84% |
| 2005 FY | 21.48 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aarti Drugs Limited | 24.32 Billion INR | -214.468% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -196.232% |
| Albert David Limited | 4.97 Billion INR | -1435.97% |
| Alembic Limited | 23.28 Billion INR | -228.457% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -16145.882% |
| Hester Biosciences Limited | 6.62 Billion INR | -1054.833% |
| Hikal Limited | 24.87 Billion INR | -207.542% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -556.507% |
| Ind-Swift Limited | 6.54 Billion INR | -1068.73% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -240.804% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -3086.266% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -992.261% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -2194.075% |
| Medico Remedies Limited | 961.95 Million INR | -7851.532% |
| Morepen Laboratories Limited | 12.93 Billion INR | -491.476% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -862.914% |
| RPG Life Sciences Limited | 5.12 Billion INR | -1391.411% |
| Sigachi Industries Limited | 6.94 Billion INR | -1001.913% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 91.05% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -239.339% |
| Themis Medicare Limited | 5.66 Billion INR | -1250.42% |
| Unichem Laboratories Limited | 31.69 Billion INR | -141.343% |
| Vaishali Pharma Limited | 799.55 Million INR | -9466.547% |
| Venus Remedies Limited | 6.26 Billion INR | -1120.267% |
| Windlas Biotech Limited | 6.26 Billion INR | -1121.483% |
| ZIM Laboratories Limited | 4.46 Billion INR | -1611.866% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -18.67% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -5079.386% |
| FDC Limited | 24.68 Billion INR | -209.916% |
| Gufic Biosciences Limited | 10.92 Billion INR | -600.111% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 33.766% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -249.101% |
| Orchid Pharma Limited | 15.53 Billion INR | -392.254% |
| Alkem Laboratories Limited | 155.74 Billion INR | 50.889% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -899.702% |
| Brooks Laboratories Limited | 904.45 Million INR | -8357.036% |
| Eris Lifesciences Limited | 70.48 Billion INR | -8.514% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -168.347% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | -225.961% |
| Innova Captab Limited | 13.2 Billion INR | -479.083% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -3423.618% |
| Wanbury Limited | 3.43 Billion INR | -2126.828% |
| Lupin Limited | 239.97 Billion INR | 68.125% |
| Sakar Healthcare Limited | 3.88 Billion INR | -1868.049% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 83.029% |
| Divi's Laboratories Limited | 154.7 Billion INR | 50.556% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -609.536% |
| Mankind Pharma Limited | 119.63 Billion INR | 36.063% |
| Sequent Scientific Limited | 15.4 Billion INR | -396.564% |
| Laurus Labs Limited | 83.87 Billion INR | 8.8% |
| Neuland Laboratories Limited | 18.32 Billion INR | -317.394% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -91.506% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 46.729% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 73.877% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -1984.931% |
| Bal Pharma Limited | 3.2 Billion INR | -2287.41% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 80.262% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -530.134% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -7427.721% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | -183.571% |
| Shilpa Medicare Limited | 30.93 Billion INR | -147.284% |
| Valiant Laboratories Limited | 3.42 Billion INR | -2132.064% |
| Ajanta Pharma Limited | 46.38 Billion INR | -64.906% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -2407.934% |
| Granules India Limited | 55.2 Billion INR | -38.544% |
| Medicamen Biotech Limited | 2.94 Billion INR | -2497.086% |
| Ipca Laboratories Limited | 111.01 Billion INR | 31.098% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -1790.211% |
| Piramal Enterprises Limited | 826.05 Billion INR | 90.74% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 49.213% |
| NATCO Pharma Limited | 69.06 Billion INR | -10.754% |
| Suven Life Sciences Limited | 2.84 Billion INR | -2584.776% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -4192.978% |
| Strides Pharma Science Limited | 58.39 Billion INR | -30.982% |
| Indoco Remedies Limited | 21.44 Billion INR | -256.642% |
| Alpa Laboratories Limited | 1.82 Billion INR | -4088.44% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -4969.971% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -1385.127% |